New Diabetes Criteria and Clinical Implications Jay S. Skyler Short Communication 22 October 2012 Pages: 1 - 2
Measurement of Insulin Resistance In Vivo Stefano Del Prato Review Article 22 October 2012 Pages: 3 - 6
General Characteristics of the Insulin Resistance Syndrome Henning Beck-Nielsen Current Opinion 22 October 2012 Pages: 7 - 10
Pathogenesis of Insulin Resistance in Type 2 Diabetes Leif C. Groop Short Communication 22 October 2012 Pages: 11 - 12
Visceral Obesity and Diabetes Per BjörntorpRoland Rosmond Review Article 22 October 2012 Pages: 13 - 18
Clinical Efficacy of Metformin against Insulin Resistance Parameters Paul ZimmetGreg Collier Review Article 22 October 2012 Pages: 21 - 28
The Antihyperglycaemic Effect of Metformin Nicolas F. WiernspergerClifford J. Bailey Review Article 22 October 2012 Pages: 31 - 39
Insulin Resistance, Polycystic Ovary Syndrome and Metformin Michel PugeatPierre Henri Ducluzeau Review Article 22 October 2012 Pages: 41 - 46
Strategies for the Management of Diabetic Dyslipidaemia Marja-Riitta Taskinen Review Article 22 October 2012 Pages: 47 - 51
Metformin Prevents Weight Gain by Reducing Dietary Intake During Insulin Therapy in Patients with Type 2 Diabetes Mellitus Hannele Yki-JärvinenK. NikkiläS. Mäkimattila Short Communication 22 October 2012 Pages: 53 - 54
Lactic Acidosis in Metformin Therapy Jean-Daniel LalauJean-Michel Race Current Opinion 22 October 2012 Pages: 55 - 60
Strategies for Better Diabetes Control in the US Alan J. Garber Review Article 22 October 2012 Pages: 61 - 69
Prevention of Type 2 Diabetes M. Aline CharlesEveline Eschwège Review Article 22 October 2012 Pages: 71 - 73